A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma

BACKGROUND: Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) require multi‐modality treatment. Immune checkpoint inhibitors (ICIs) are now standard of care in management of recurrent/metastatic HNSCC. However, its role in the definitive and neoadjuvant setting remains unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nindra, Udit, Hurwitz, Joshua, Forstner, Dion, Chin, Venessa, Gallagher, Richard, Liu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
REVIEW
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242857/
https://www.ncbi.nlm.nih.gov/pubmed/36934434
http://dx.doi.org/10.1002/cam4.5815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242857/
https://www.ncbi.nlm.nih.gov/pubmed/36934434
http://dx.doi.org/10.1002/cam4.5815

Ejemplares similares